Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family

International Journal of Cancer

Volumn 86, Issue 5, 2000, Pages 749-751

  Rimoldi, Donata ^a   Salvi, Suzanne ^a   Schultz Thater, Elke ^b   Spagnoli, Giulio C ^b   Cerottini, Jean Charles ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CROSS REACTING ANTIBODY; EPITOPE; HLA ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANTIGEN RECOGNITION; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; FIBROSARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LETTER; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CROSS REACTIONS; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0034062277     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000601)86:5<749::AID-IJC24>3.3.CO;2-F     Document Type: Letter

References (15)

1. CARREL, S., SCHREYER, M., SPAGNOLI, G., CEROTTINI, J.C. and RIMOLDI, D., Monoclonal antibodies against r-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells. Int. J. Cancer, 67, 417-422 (1996).
2. CHAUX, P., VANTOMME, V., STROOBANT, V., THIELEMANS, K., CORTHALS, J., LUITEN, R., EGGERMONT, A. M. M., BOON, T. and VAN DER BRUGGEN P., Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes. J. exp. Med., 189, 767-778 (1999).
3. CHEN, Y.-T., STOCKERT, E., CHEN, Y., GARIN-CHESA, P., RETTIG, W. J., VAN DER BRUGGEN, P., BOON, T. and OLD, L. J., Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc. nat. Acad. Sci. (Wash.), 91, 1004-1008 (1994).
4. DE PLAEN, E., and 14 OTHERS, Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics, 40, 360-369 (1994).
5. HOFBAUER, G. F., SCHAEFER, C., NOPPEN, C., BONI, R., KAMARASHEV, J., NESTLE, F. O., SPAGNOLI, G. and DUMMER, R., MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution. Amer. J. Pathol., 151, 1549-1553 (1997).
6. HUANG, L-Q., BRASSEUR, F., SERRANO, A., DE PLAEN, E., VAN DER BRUGGEN, P., BOON, T. and VAN PEL, A., Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma. J. Immunol., 162, 6849-6854 (1999).
7. JURK, M., KREMMER, E., SCHWARZ, U., FORSTER, R. and WINNACKER, E.L., MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus. Int. J. Cancer, 75, 762-766 (1998).
8. KOCHER, T., SCHULTZ-THATER, E., GUDAT, F., SCHAEFER, C., CASORATI, G., JURETIC, A., WILLIMANN, T., HARDER, F., HEBERER, M. and SPAGNOLI, G.C. Identification and intracellular location of MAGE-3 gene product. Cancer Res., 55, 2236-2239 (1995).
9. MANICI, S., STURNIOLO, T., IMRO, M. A., HAMMER, J., SINIGAGLIA, F., NOPPEN, C., SPAGNOLI, G., MAZZI, B., BELLONE, M., DELLABONA, P. and PROTTI, M. P., Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J. Exp. Med., 189, 871-876 (1999).
10. MARCHAND, M. and 24 OTHERS, Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer, 80, 219-230 (1999).
11. NESTLE, F. O., ALIJAGIC, S., GILLIET, Y., SUN, S., GRABBE, S., DUMMER, R., BURG, G. and SCHADENDORF, D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature (Med.), 4, 328-332 (1998).
12. RIMOLDI, D., SALVI, D., REED, D., COULIE, P., JONGENEEL, V.C., DE PLAEN, E., BRASSEUR, F., RODRIGUEZ, A-M., BOON, T. and CEROTTINI J.-C., cDNA and protein characterization of human MAGE-10. Int. J. Cancer, 32, 901-907 (1999).
13. SHICHIJO, S., TSUNOSUE, R., KUBO, K., KURAMOTO, T., TANAKA, Y., HAYASHI, A. and ITOH, K., Establishment of an enzyme-linked immunosorbent assay (ELISA) for measuring cellular MAGE-4 protein on human cancers. J. immunol. Methods, 186, 137-149 (1995).
14. VAN DEN EYNDE, B. J. and VAN DER BRUGGEN, P. T cell defined tumor antigens. Curr. Opin. Immunol., 9, 684-693 (1997).
15. ZORN, E. and HERCEND, T., A MAGE-6 encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion. Eur. J. Immunol., 29, 602-607 (1999).